Navigation Links
Potential new strategy to reduce catheter blockage
Date:4/12/2011

Bacterial genes that make urine less acidic could be good targets to prevent catheter blockage, according to research presented at the Society for General Microbiology's Spring Conference in Harrogate. The findings could lead to new strategies to prevent serious infections, particularly in long-term catheterization patients.

Urinary catheters are devices used in hospitals and community care homes to manage a range of bladder conditions, and are commonly used to manage incontinence in elderly individuals for long periods of time. Scientists from the University of Brighton, led by Dr Brian Jones, are looking at the bacterium Proteus mirabilis - a common cause of urinary tract infections in patients undergoing long-term catheterization, which often leads to serious complications.

P. mirabilis cells can stick together on catheter surfaces where they form highly organized communities called biofilms. As the bacterium breaks down urea (using the enzyme urease) it causes the pH of urine to rise, leading to the formation of insoluble crystals which become trapped in the growing biofilm. The crystalline deposits can form a crust on the catheter and may eventually block urine flow from the bladder. If unnoticed, catheter blockage can lead to kidney and bloodstream infections, which ultimately may result in potentially fatal septic shock.

The team is identifying genes involved in P. mirabilis biofilm formation, and assessing their contribution to catheter blockage. The results show that biofilm-forming ability may be less important to catheter blockage than previously thought, and suggest that inhibiting the rise in urinary pH is a primary target for preventing catheter blockage. Nina Holling who is carrying out the research said, "In our experiments we have found biofilm-forming ability not to be the most important factor in catheter blockage. Although biofilm formation does play a role, the ability of P. mirabilis'/>"/>

Contact: Laura Udakis
l.udakis@sgm.ac.uk
44-118-988-1843
Society for General Microbiology
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. New potential atherosclerosis risk marker discovered
2. New drug shows potential for treatment-resistant leukemia
3. Scientists find potential benefit of hypericin for recurrent brain tumors
4. Study Probes Potential Link Between Welding, Parkinsons Disease
5. Researchers mimic bodys own healing potential to create personalised therapies for inflammation
6. U-M scientists find potential driver of some aggressive prostate cancers
7. Heart drug cuts prostate cancer risk; holds potential for therapeutic use
8. For potentially crippling dystonia, earlier deep brain therapy gets better, quicker results
9. In pilot study, screening detects potentially serious heart conditions in healthy children
10. New vaccine candidate shows strong potential to prevent highly contagious norovirus
11. Potential new treatment to reduce the burden of atherosclerosis in acute coronary syndrome patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Potential new strategy to reduce catheter blockage
(Date:7/31/2015)... ... July 31, 2015 , ... The 2nd annual Ride to Fight On will ... October 3, 2015. The Ride to Fight On is a cycling fundraiser that benefits ... The West Clinic and The University of Tennessee Health Science Center. A health and ...
(Date:7/31/2015)... ... 31, 2015 , ... Coco Libre announced today that their flagship Organic Coconut ... 2015 Vans US Open of Surfing, July 25 through August 2 in Huntington Beach, ... on the market, is a natural choice given the Open’s commitment to sustainable practices. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Well-known for its unique pastries ... wedding cakes with custom designs, making life just a little bit sweeter for ... cakes for each customer who orders one. , The bakery provides a full line ...
(Date:7/31/2015)... ... 2015 , ... Transfinder, a software company based in Schenectady, N.Y., achieved record ... year-over-year for the first six months ended June 30, 2015 compared with the same ... last year’s record-revenue mark of $10.4 million. , “We know what our customers need ...
(Date:7/31/2015)... NY (PRWEB) , ... July 31, 2015 , ... The ... marijuana, on research projects that evaluate the potential of related, experimental treatments. The collaboration ... Department of Health to award Columbia Care one of five state licenses to produce ...
Breaking Medicine News(10 mins):Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3
... students to benefit from program targeting kids in five-county ... American dream -- that children have more opportunities and ... at risk as the incidence of obesity among children ... could become the first in this country,s history to ...
... Andre Konski, M.D., M.B.A., has been offered ... Department of Radiation Oncology for the Wayne ... Chief for Radiation Oncology at the Barbara Ann ... Konski comes to Wayne State and ...
... Pierre,s Ice Cream Company, makers of,Hola Fruta!(R) ... innovation,called Yovation(TM). , (Photo: ... Yovation(TM) is a new premium, probiotic frozen ... and popularity of probiotic products and the,recognition by ...
... Plans Thousands of Franchisees Nationally With More than 1,800 ... eMed-ID, the world,s first medical identification franchise, announced today ... provides a personal USB device to consumers containing their ... for consumers to document their private medical history on ...
... Jan. 9 (HealthDay News) -- Parents may not always ... exercise habits, a new study shows. , Researchers reported ... Education and Behavior that mothers of preschool-aged children ... with older children did not. But when the children ...
... enhanced website designed to provide improved accessibility and ... Labs, a Zeus company, announces the launch of ... via the original URL and can be found ... with expanded content, including more information about Polymathic,s ...
Cached Medicine News:Health News:The Archdiocese of Philadelphia and Independence Blue Cross Team Up to Address Childhood Obesity 2Health News:The Archdiocese of Philadelphia and Independence Blue Cross Team Up to Address Childhood Obesity 3Health News:The Archdiocese of Philadelphia and Independence Blue Cross Team Up to Address Childhood Obesity 4Health News:Andre Konski, M.D., M.B.A., Accepts Radiation Oncology Position at Wayne State University and the Karmanos Cancer Institute 2Health News:Andre Konski, M.D., M.B.A., Accepts Radiation Oncology Position at Wayne State University and the Karmanos Cancer Institute 3Health News:Standing Ovation for Pierre's New Innovation! 2Health News:Standing Ovation for Pierre's New Innovation! 3Health News:World's First Medical Identification Franchise Launches at Miami's Franchise Expo South 2Health News:World's First Medical Identification Franchise Launches at Miami's Franchise Expo South 3Health News:Parents Not Best Barometer of Kid's Eating, Exercise Habits 2Health News:Polymathic Analytical Labs Launches New Website 2
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
(Date:7/30/2015)... PLAINFIELD, N.J., July 30, 2015 PTC Therapeutics, ... update and reported financial results for the second quarter ... progressing on many fronts across the organization.  We are ... Duchenne muscular dystrophy clinical trial ever conducted with topline ... Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. "Translarna ...
(Date:7/30/2015)... -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ) ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics ... notice it received on May 21, 2015 from the ... was below certain of the Exchange,s continued listing standards, ... the NYSE MKT Company Guide, due to the delay ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
... MASI ) today announced that its management is scheduled ... The Pierre Hotel in New York on Tuesday, November 15, ... the presentation will be available on the Masimo website at ... available following the live presentation. About ...
... Nov. 8, 2011 ChemoCentryx, Inc., today announced that ... the Annual Meeting of the American College of Rheumatology ... targets and inhibits the chemokine receptor known as CCR1, ... rheumatoid arthritis (RA).  Results showed that CCX354 was safe ...
Cached Medicine Technology:Masimo to Present at Lazard Capital Markets Healthcare Conference 2ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthritis 2ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthritis 3ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthritis 4
Multipiece PMMA IOL - Sulcus Fixation....
Hydrophilic Acrylic Intraocular Lens (Refractive and Bifocal). Anterior Chamber Lens....
Raysoft Foldable Intraocular Lens....
HAPTIBAG Hydrophilic Acrylic Lens....
Medicine Products: